Preliminary results from a phase 1/2 study of INCB054828, a highly selective fibroblast growth factor receptor (FGFR) inhibitor, in patients with advanced malignancies

被引：8
作者：
Saleh, Mansoor
Gutierrez, Martin E.
Subbiah, Vivek
Smith, David C.
Asatiani, Ekaterine
Lihou, Christine F.
Zhen, Huiling
Yeleswaram, Swamy
Ji, Tao
Nemunaitis, John
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-CT111
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT111
引用
收藏
页数：2
相关论文
共 50 条
[41]   Tinengotinib, a novel fibroblast growth factor receptor (FGFR) inhibitor, is potent against resistance mutations in FGFR1/2/3 [J].
Qiang, Xiaoyan ;
Yu, Qi ;
Fan, Jean ;
Wu, Frank ;
Sun, Caixia ;
Peng, Peng .
CANCER RESEARCH, 2023, 83 (08)
[42]   Phase I study of the irreversible fibroblast growth factor receptor 1-4 inhibitor futibatinib in Japanese patients with advanced solid tumors [J].
Doi, Toshihiko ;
Shitara, Kohei ;
Kojima, Takashi ;
Kuboki, Yasutoshi ;
Matsubara, Nobuaki ;
Bando, Hideaki ;
Yoh, Kiyotaka ;
Naito, Yoichi ;
Hirai, Hiroshi ;
Kurokawa, Yukinori ;
Kato, Terufumi ;
Morizane, Chigusa .
CANCER SCIENCE, 2023, 114 (02) :574-585
[43]   Discovery of BW710 as a potent, selective and orally bioavailable fibroblast growth factor receptor 2 (FGFR2) inhibitor [J].
Yang, Bowen ;
Xun, Qiuju ;
Tian, Yuan ;
Li, Huiqiong ;
Wu, Pinglian ;
Zhou, Yang ;
Chang, Shaohua ;
Wang, Zhen ;
Ding, Ke ;
Ma, Dawei .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 287
[44]   Phase I study of fibroblast growth factor receptor 2 antibody-drug conjugate (FGFR2-ADC) BAY 1187982 in patients with advanced cancer [J].
Kim, Sung-Bae ;
Meric-Bernstam, Funda ;
Berlin, Jordan ;
Wittemer-Rump, Sabine ;
Osada, Motonobu ;
Valencia, Ray ;
Babich, Aleksei ;
Liu, Rong ;
Hwang, Andy ;
Tanigawa, Takahiko ;
Reetz, Frank ;
Laurent, Dirk ;
Kalyan, Aparna .
CANCER RESEARCH, 2017, 77
[45]   A Phase 2 Study of Erdafitinib in Patients with Advanced Solid Tumors and Fibroblast Growth Factor Receptor Gene Alterations [J].
Pant, S. ;
Tabernero, J. ;
Massard, C. ;
Hyman, D. M. ;
Witt, O. ;
Doi, T. ;
Qin, S. ;
Lu-Emerson, C. ;
Hargrave, D. ;
Garcia-Corbacho, J. ;
Little, S. ;
Tolbert, J. ;
Santiago-Walker, A. ;
Moy, C. ;
Hammond, C. ;
Lau, Y. Y. ;
Sweiti, H. ;
Schuler, M. .
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) :S673-S673
[46]   First-in-human phase I study of E7090, a novel selective fibroblast growth factor receptor inhibitor, in patients with advanced solid tumors [J].
Koyama, Takafumi ;
Shimizu, Toshio ;
Iwasa, Satoru ;
Fujiwara, Yutaka ;
Kondo, Shunsuke ;
Kitano, Shigehisa ;
Yonemori, Kan ;
Shimomura, Akihiko ;
Iizumi, Sakura ;
Sasaki, Tatsuya ;
Furuse, Junji ;
Yamamoto, Noboru .
CANCER SCIENCE, 2020, 111 (02) :571-579
[47]   A novel mRNA-based patient selection strategy identifies fibroblast growth factor receptor (FGFR) inhibitor-sensitive tumors: Results from rogaratinib Phase-1 study [J].
Joerger, M. ;
Soo, R. A. ;
Cho, B. C. ;
Navarro, A. ;
Sayehli, C. M. ;
Richly, H. ;
Tai, D. ;
Kim, D-W. ;
Wolf, J. ;
Cassier, P. ;
Bender, S. ;
Ellinghaus, P. ;
Ince, S. ;
Rajagopalan, P. ;
Ocker, M. ;
Schuler, M. .
ANNALS OF ONCOLOGY, 2017, 28
[48]   Preliminary results from fight-102: a phase 1 study of pemigatinib in Japanese patients with advanced malignancies [J].
Kuboki, Yasutoshi ;
Furukawa, Masayuki ;
Takahashi, Yasuo ;
Mizuno, Nobumasa ;
Hara, Hiroki ;
Ueno, Makoto ;
Ioka, Tatsuya ;
Takahashi, Shunji ;
Shimizu, Toshio ;
Lihou, Christine F. ;
Tian, Chenwei ;
Ji, Tao ;
Fujiwara, Yutaka .
ANNALS OF ONCOLOGY, 2019, 30
[49]   A Phase 2 Study of Futibatinib (TAS-120) in Patients with Myeloid or Lymphoid Neoplasms Harboring Fibroblast Growth Factor Receptor (FGFR) 1 Rearrangements [J].
Kiladjian, Jean-Jacques ;
Shitara, Kohei ;
Rosen, Lee Stephen ;
Rha, Sun Young ;
He, Aiwu ;
Oh, Do-Youn ;
Melisi, Davide ;
Iwasa, Satoru ;
Jiang, Yixing ;
Liu, Sherry ;
Takahashi, Osamu ;
Ribrag, Vincent .
BLOOD, 2021, 138 :3656-+
[50]   FIGHT-207: Phase 2 study of pemigatinib in patients with previously treated, locally advanced/metastatic or unresectable solid tumor malignancies harboring activating fibroblast growth factor receptor (FGFR) gene alterations [J].
Feliz, Luis ;
Asatiani, Ekaterine ;
Lihou, Christine ;
Zhen, Huiling ;
Silverman, Ian ;
Ahnert, Jordi Rodon .
MOLECULAR CANCER THERAPEUTICS, 2019, 18 (12)
12345